Non-Hodgkin Lymphoma in an HIV-Infected Patient: A Case Report

Penulis

  • Ni Made Renny Anggreni Rena
  • I Nyoman Agus Subagiartha
  • Ketut Suega

DOI:

https://doi.org/10.56951/txg4jt82

Kata Kunci:

HIV/AIDS-associated lymphoma, non-Hodgkin lymphoma (NHL), HIV infection

Abstrak

Introduction: Lymphoma is one of the hematologic malignancies that occur at a higher rate in individuals infected with human immunodeficiency virus (HIV). Management of HIV/AIDS-associated lymphoma consists of establishing the precise histological subtype, assessing performance status, and evaluating the burden of the coexisting comorbidities. The treatment aims to achieve clinical improvement and enhance quality of life. This case report describes our experience in evaluating and managing a patient with HIV-associated non-Hodgkin lymphoma at RSUP Prof. dr. I.G.N.G. Ngoerah, Denpasar, Bali, Indonesia. Case presentation: A 27-year-old male with HIV infection was admitted to the emergency room due to generalized weakness for three weeks. The patient also complained of a lump in the right nostril. The lump was approximately the size of a marble, with solid consistency, skin-colored appearance, and no associated pain. The patient had a history of HIV infection since May 2021 and was already undergoing regular treatment with antiretroviral drugs. A series of tests, computed tomography (CT) scan, immunohistochemistry (IHC) and biopsy were performed after admission. He was treated with continuing antiretroviral therapy and chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen. The patient showed good adherence to therapy. Conclusions: Although antiretroviral therapy has significantly reduced the incidence of HIV-associated non-Hodgkin lymphoma subtypes, it remains the most common cause of morbidity and mortality in these patients compared to the general population. Awareness and knowledge of lymphoma in people with HIV/AIDS is essential to improve their survival and recovery. In addition, early identification of the etiology of lymphoma is essential for the physician to facilitate early prevention of lymphoma complications.

Referensi

1. Berhan A, Bayleyegn B, Getaneh Z. HIV/AIDS-associated lymphoma: review. Blood Lymphat Cancer. 2022;12:31–45. doi:10.2147/BLCTT.S361320.

2. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. p. 296–300.

3. Khwaja J, Burns JE, Ahmed N, Cwynarski K. HIV-associated lymphoma—advances in clinical management. Ann Lymphoma. 2021;5:1–20. doi:10.21037/aol-21-16.

4. de Carvalho PS, Leal FE, Soares MA. Clinical and molecular properties of human immunodeficiency virusrelated diffuse large B-cell lymphoma. Front Oncol. 2021;11:675353. doi:10.3389/fonc.2021.675353.

5. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90. doi:10.1182/blood-2016-01-643569.

6. Bakta IM. Hematologi klinik ringkas. Jakarta: EGC; 2006.

7. Pongas GN, Ramos JC. HIV-associated lymphomas: progress and new challenges. J Clin Med. 2022;11(5):1447. doi:10.3390/jcm11051447.

8. Milligan MG, Bigger E, Abramson JS, Sohani AR, Zola M, Kayembe MKA, et al. Impact of HIV infection on the clinical presentation and survival of non-Hodgkin lymphoma: a prospective observational study from Botswana. J Glob Oncol. 2018;4:1–11. doi:10.1200/JGO.17.00084.

9. Boyiadzis MM, Frame JN, Kohler DR, Fojo T, editors. Hematology-oncology therapy. 2nd ed. New York: McGraw-Hill Education; 2014. p. 684–95.

Diterbitkan

01-11-2026

Unduhan

Data unduhan tidak tersedia.

Cara Mengutip

[1]
Non-Hodgkin Lymphoma in an HIV-Infected Patient: A Case Report. MEDICINUS 2026;39:42-7. https://doi.org/10.56951/txg4jt82.